More About Us
The Australian Prostate Cancer Research Centre–Queensland is a disease-specific, multidisciplinary, highly collaborative prostate cancer research centre focusing on the development of new therapeutics and biomarkers for prostate cancer and their translation into the clinical setting. Located within the state-of-the-art Translational Research Institute in Brisbane, the APCRC–Q forms a hub for prostate cancer research in Queensland.
More >
APCRC-Q News
This book chapter by Dr Philp et al aims to serve as a comprehensive resource for the preparation and adoption of PCa PDX models in the research laboratory and for their use as a valuable preclinical platform for translational research and therapeutic agent development. More >
Great team effort for our Movember 2023 Fundraising sale - making a difference in the community, in research and in peoples’ lives! More >
Our amazing team has raised $2702 from our bake sale to support the Princess Alexandra Hospital Giving Day 2023. More >
Metformin, the first line pharmacotherapy for type 2 diabetes has demonstrated favourable effects in prostate cancer (PCa) across a range of studies evaluating PCa patient outcomes amongst metformin users. This review by Dr Gunter et al highlights the potential of metformin to be repurposed as an anticancer agent, warranting further investigation of metformin in the setting of PCa. More >
In this study, we introduce Precily, a predictive modeling approach to infer treatment response in cancers using gene expression data. We assessed the predictability of treatment outcomes and demonstrated the applicability of our approach on patient drug response data. More >
